Australia markets close in 37 minutes

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
27.00+0.03 (+0.11%)
At close: 04:00PM EDT
27.00 0.00 (0.00%)
After hours: 04:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close26.97
Open26.90
Bid0.00 x 1400
Ask0.00 x 900
Day's range25.16 - 27.36
52-week range19.59 - 46.16
Volume302,612
Avg. volume461,895
Market cap4.004B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.71
Earnings date09 Aug 2022 - 15 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est40.50
  • GlobeNewswire

    Cerevel Therapeutics Announces Updates to its Board of Directors

    CAMBRIDGE, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today that it has appointed Suneet Varma to serve as a member of its board of directors. Mr. Varma succeeds Morris Birnbaum, M.D., Ph.D., who announced that he is retiring from his role as Senior Vice President and Chief Scientific Officer of Internal Medicine at Pfizer Inc., and will therefore be stepping

  • GlobeNewswire

    Cerevel Therapeutics to Present at the Jefferies Healthcare Conference

    CAMBRIDGE, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that chairperson and chief executive officer Tony Coles, M.D. will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8 at 10:30 am ET. The live webcast of the fireside chat can be accessed on the investor relations section of the Cerevel Therapeutics website here. A rep

  • Simply Wall St.

    Here's Why We're Not Too Worried About Cerevel Therapeutics Holdings' (NASDAQ:CERE) Cash Burn Situation

    We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...